CraigThomasCurtisMD

Research • Orlando, FL

Chief Medical Officer Compass Research/Bioclinica

Join to view full profile

Dr. Curtis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Curtis' full profile

Already have an account?

Office
100 West Gore Street
Orlando, FL 32806
Phone+1 407-426-9299
Is this information wrong?

Education & Training

St Vincent's Medical CenterResidency, Family Medicine, 2000 - 2002
Emory University School of MedicineResidency, Radiation Oncology, 1997 - 1998
AdventHealth FloridaInternship, Transitional Year, 1996 - 1997
Northeast Ohio Medical UniversityClass of 1996

Certifications & Licensure

FL State Medical License 1999 - 2026

Clinical Trials

An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease Start of enrollment: 2009 Nov 01
Completed
Phase 1
The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Start of enrollment: 2013 Dec 01
Completed
Phase 2, Phase 3
A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects Start of enrollment: 2014 Aug 01
Completed
Phase 1
18F-AV-1451 Autopsy Study Start of enrollment: 2015 Sep 01
Completed
Phase 3
A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD Start of enrollment: 2015 Dec 22
Completed
Phase 1
A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Start of enrollment: 2017 Jan 31
Completed
Phase 1
Join now to see all